A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without Food

NCT05155306 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 1358894, intended Commercial Formulation (iCF) (T)
DRUG: BI 1358894, Trial Formulation 2 (TFII) (R)

Sponsor

Boehringer Ingelheim